menu search

intellia therapeutics will soon make biotech history. is the stock a buy?

intellia will soon start a phase 3 gene-editing trial, the first of its kind. Succeeding with the trial...

October 28, 2023, 7:30 am

intellia (ntla) focuses on developing gene-editing therapies

intellia's (NTLA) in-vivo CRISPR-based gene-edited therapy candidate NTLA-2001 holds potential. Other p...

October 23, 2023, 11:18 am

intellia's (ntla) ind for gene-editing therapy gets fda clearance

intellia (NTLA) gets FDA nod to begin a phase III study on its gene editing candidate, NTLA-2001 to tre...

October 19, 2023, 12:47 pm

intellia's (ntla) hae candidate gets ema's prime designation

The European Medicines Agency bestows a Priority Medicines (PRIME) designation to intellia's (NTLA) in ...

October 16, 2023, 2:17 pm

Down 45%, is intellia a buy?

intellia has declined over the past year even as its candidates for severe diseases have advanced in cl...

October 10, 2023, 2:00 pm

This cathie wood stock is poised to double, says wall street

intellia's leading candidates look promising, but there's a long way to go before they hit the market. ...

October 10, 2023, 10:07 am

intellia therapeutics could rise 167%, per wall street, but is it a buy?

intellia Therapeutics has a pair of promising gene-editing therapies in the works. It also has a highly...

October 3, 2023, 10:07 am

Regeneron, intellia therapeutics expand research collaboration to make gene editing therapies

Regeneron Pharmaceuticals and intellia Therapeutics have expanded their research collaboration to devel...

October 3, 2023, 7:10 am

Better gene editing stock: intellia therapeutics vs. rocket pharmaceuticals

Rocket Pharmaceuticals has two programs approaching commercialization. By contrast, intellia's candidat...

September 23, 2023, 9:45 am

These 2 stocks could skyrocket by 54% and 119%, according to wall street

Editas Medicine encountered problems with one of its top candidates last year, while the other still has a long way to go. ...

August 23, 2023, 8:25 am

intellia (ntla) misses on q2 earnings, gives pipeline update

intellia's (NTLA) second-quarter earnings miss estimates. The company provides an update on its gene-ed...

August 4, 2023, 12:02 pm

intellia therapeutics, inc. (ntla) reports q2 loss, misses revenue estimates

intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.40 per share versus the Zacks C...

August 3, 2023, 10:32 am

intellia therapeutics to hold conference call to discuss second quarter 2023 earnings and company updates

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- intellia Therapeutics, Inc. (NASDAQ:NTLA), a leadin...

July 27, 2023, 7:30 am

intellia therapeutics: the future is here

intellia is a pipeline-stage firm, leveraging gene-editing technology to develop therapies for rare dis...

July 26, 2023, 11:18 pm

Biotech and biopharma executive eliana clark joins culture biosciences’ advisory board

The recently established group of senior industry leaders provides guidance as the company executes its growth strategy SAN FRANCISCO, July 19, 2023 (...

July 19, 2023, 10:39 am

Wall street expects intellia therapeutics stock to climb 107%. is that too optimistic?

intellia Therapeutics won't be commercializing a drug within a year. It also won't be reporting pivotal...

June 23, 2023, 4:45 pm

Cathie wood is buying this growth stock and selling its competitor. should you follow suit?

Cathie Wood has been loading up on intellia Therapeutics. She's also trimming her holdings of CRISPR Th...

June 21, 2023, 9:45 am

Got $1,000? 3 growth stocks to buy that could double your money.

Alibaba has tremendous growth opportunities in AI. intellia Therapeutics' gene-editing therapies hold t...

June 20, 2023, 5:50 am


Search within

Pages Search Results: